Quantcast

Latest Nursing research Stories

2014-09-11 23:02:43

A research team from the Icahn School of Medicine at Mount Sinai today received a $12 million grant from the National Institutes of Health to create a center that will screen massive data sets for new uses of existing drugs, and confirm them in human cell tests. New York, NY (PRWEB) September 11, 2014 A research team from the Icahn School of Medicine at Mount Sinai today received a $12 million grant from the National Institutes of Health to create a center that will screen massive data...

2014-09-08 08:30:20

- Data show improvements in hemodynamic parameters and exercise capacity SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported top-line results from a Phase 2 study of AIR001 (sodium nitrite) inhalation solution for the treatment of pulmonary arterial hypertension (PAH). Mast obtained the rights to the AIR001 program through its acquisition of privately-held Aires Pharmaceuticals, Inc. earlier this year. In the primary efficacy analysis...

2014-09-05 08:24:09

BETHESDA, Md., Sept. 5, 2014 /PRNewswire-USNewswire/ -- The Foundation for Advanced Education in the Sciences (FAES) is pleased to announce the launch of a new professional development training program, drawing on a long and distinguished history of providing advanced education for 55 years as well as delivering biotechnology training and lab workshops for 27 years at the National Institutes of Health (NIH). Building on our long-term ties with the biomedical community, the new program will...

2014-08-29 23:09:19

Clinical Trial Magnifier Weekly monitors 150,000 trials in 185 countries around the world every week and reports all the fresh changes. By sifting through tens of thousands of records, FDAnews is able to extract just the information readers need. Falls Church, VA (PRWEB) August 29, 2014 http://www.fdanews.com/CTMPR FDAnews is proud to announce the release of Clinical Trials Magnifier Weekly. Clinical Trial Magnifier Weekly monitors 150,000 trials in 185 countries around the world every...

2014-08-29 08:24:27

Investor update call to be held Tuesday, September 2 VANCOUVER, British Columbia and MENLO PARK, Calif., Aug. 29, 2014 /PR Newswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing of June 30, 2014 fiscal year-end financial statements. The Company recently changed its fiscal year end to June 30th in order to facilitate an application to list its common stock on a national securities exchange in the timeliest manner possible. DelMar's...

2014-08-28 12:30:53

DENVER, Aug. 28, 2014 /PRNewswire/ -- Pharmatech initiated enrollment for its AccessPPM program after a two-year investment into this game-changing method for matching cancer patients to cancer clinical trials. Today, clinical trials target specific cancers, disease staging, and genetic mutations - which may be contributing factors for the cancer, in the first place. The challenge that the industry faces, is that this information may not be well known to the patient or even their...

2014-08-21 08:28:33

ENGLEWOOD, Colo., Aug. 21, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a delay in the data analysis of the STEP Study due to the discovery by the independent Clinical Research Organization (CRO) that the study drug (both Ampion(TM) and the placebo) were, during shipment to the clinical sites, exposed to lower temperatures than permitted by the drug specifications. http://photos.prnewswire.com/prnvar/20120516/MM09116LOGO Michael Macaluso, Ampio's...

2014-08-14 08:28:23

-- Expanded Data from Phase II MS Trial to be Released Next Month; Plans on Course to Advance C. difficile and C-IBS Programs into the Clinic During 2014 -- ROCKVILLE, Md., Aug. 14, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, today reported financial results for the three and six months ended June 30, 2014, and provided an operational...

2014-08-07 16:28:49

SAN DIEGO, Aug. 7, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today reported its financial results for the three months and six months ended June 30, 2014. http://photos.prnewswire.com/prnvar/20120620/LA28014LOGO "Trovagene is continuing to demonstrate the benefits of our precision cancer monitoring platform and is progressing toward our commercial roll-out later this year," said Antonius Schuh, Ph.D., chief executive officer of...

2014-07-15 12:29:19

Society Joins Coalition of More than 90 Organizations in Calling on Congress to Stop Cuts to Federal Health Programs that Keep Americans Healthy and Safe WASHINGTON, July 15, 2014 /PRNewswire-USNewswire/ -- A new report released today and supported by the American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, details the dire consequences of recent deep budget cuts to federal health programs,...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.